Your browser doesn't support javascript.
loading
Therapeutic apheresis in the treatment of catastrophic antiphospholipid syndrome.
Özgür, Gökhan; Beyan, Cengiz.
Affiliation
  • Özgür G; Gulhane Training and Research Hospital, Department of Hematology, Ankara, Turkey. Electronic address: gokhan.ozgur2@saglik.gov.tr.
  • Beyan C; TOBB University of Economics and Technology, Faculty of Medicine, Department of Internal Medicine, Ankara, Turkey.
Transfus Apher Sci ; 57(1): 13-15, 2018 Feb.
Article in En | MEDLINE | ID: mdl-29478799
Catastrophic thrombotic syndrome is characterized by occurrence of several thromboembolic occlusions which affect a variety of vascular beds over a short period of time. Catastrophic Antiphospholipid syndrome (CAPS) (1%) is regarded as a rare but severe variant of Antiphospholipid Syndrome. Treatment with anticoagulants, steroids and therapeutic plasma exchange has been shown to give the best results. However, to treat CAPS, the best substitute for plasma is still a debatable issue because there are no standard methods.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasma Exchange / Steroids / Thromboembolism / Antiphospholipid Syndrome / Anticoagulants Type of study: Etiology_studies Limits: Humans Language: En Journal: Transfus Apher Sci Journal subject: HEMATOLOGIA Year: 2018 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plasma Exchange / Steroids / Thromboembolism / Antiphospholipid Syndrome / Anticoagulants Type of study: Etiology_studies Limits: Humans Language: En Journal: Transfus Apher Sci Journal subject: HEMATOLOGIA Year: 2018 Document type: Article Country of publication: United kingdom